Description
- Product Overview: Roxtal XP 250® is a combination antibiotic formulation containing Cefuroxime and Clavulanic Acid, designed to treat a wide range of bacterial infections and improve antibacterial effectiveness.
- Composition: Cefuroxime USP 250 mg | Clavulanic Acid BP 62.5 mg | Dosage Form: Tablet
- Pharmacological Class: Cephalosporin Antibiotic + Beta-lactamase Inhibitor
- Mechanism of Action: Cefuroxime inhibits bacterial cell wall synthesis leading to bacterial death, while Clavulanic Acid inhibits beta-lactamase enzymes, preventing bacterial resistance and enhancing antibiotic efficacy.
- Indications: Respiratory tract infections | Urinary tract infections | Skin and soft tissue infections | ENT infections | Sinusitis | Bronchitis
- Dosage & Administration: As directed by physician only | Oral use | Usually taken after food to reduce gastric discomfort | Complete full course as prescribed
- Clinical Benefits: Broad-spectrum antibacterial action | Effective against resistant bacteria | Treats multiple infection types | Helps prevent recurrence of infection
- Contraindications: Hypersensitivity to Cephalosporins, Penicillins, or Clavulanic Acid
- Precautions: Use cautiously in patients with kidney impairment | May cause antibiotic-associated diarrhea | Complete full course to avoid resistance
- Drug Interactions: May interact with anticoagulants, probenecid, and other antibiotics
- Special Populations: Use in pregnancy and lactation only if clearly needed and prescribed | Dose adjustment may be required in renal impairment
- Adverse Effects: Diarrhea | Nausea | Abdominal discomfort | Rash | Allergic reactions (rare)
- Storage Conditions: Store below 30°C | Protect from light and moisture | Keep out of reach of children
- Packaging: Tablet blister pack
- Manufacturer: Everest Pharmaceutical Ltd.
Reviews
There are no reviews yet.